CDC Recommends Pfizer, Moderna COVID-19 Vaccines Over Johnson & Johnson

The Centers for Disease Control and Prevention (CDC) recommended the Pfizer and Moderna COVID-19 vaccines be preferred for adults over the Johnson & Johnson (J&J) vaccine due to rare blood clots cases.

The recommendation from CDC Director Dr. Rochelle Walensky came hours after a CDC advisory panel voted in favor of mRNA vaccines as the “preferred” options for adults over the J&J vaccine after a review of data on a small number of rare but dangerous blood clots linked to the J&J vaccine.

“Today’s updated recommendation emphasizes CDC’s commitment to provide real-time scientific information to the American public. I continue to encourage all Americans to get vaccinated and boosted,” Walensky said.

The Advisory Committee on Immunization Practices on Dec. 16 said that at least 54 people in the United States who have gotten the J&J vaccine have been hospitalized with a blood clotting condition known as thrombosis with thrombocytopenia.

Of the patients, who are mostly women, nine have already died.

The panel said that they would not prohibit the use of the J&J vaccine but recommends people to opt for the Pfizer or Moderna vaccine when there is a choice.

“If we take away the Jansen vaccine, and people… cannot get the mRNA vaccine, we have all these complications from getting COVID disease. And so even though there are significant risks to the vaccine, if it’s the only one that is an option, I want it to be available,” Dr. Jamie Loehr, a panel member, said.

However, some panel members were determined to avoid the J&J vaccine.

“I really cannot recommend a vaccine that has been associated with a condition that may lead to death,” Dr. Pablo Sanchez said.


© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.